Could Moderna/Merck Cancer Vaccine Succeed Where Others Have Flopped?

 
• By Alaric DeArment
  
Moderna and Merck unveiled long-awaited data from their Phase IIb study of cancer vaccine mRNA-4157 in melanoma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer